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Abstract
Background: Community pharmacists are increasingly acknowledged as under-utilized, important and
accessible health providers in providing harm reduction support to drug users via needle and syringe
programmes (NSP), provision of advice, HIV/Hepatitis testing and as referral mechanism to social,
medical and treatment services. We report here on qualitative ﬁndings as part of the evaluation of the pilot
Pharmacy Needle Exchange (PNEX) programme in Ireland.
Objectives: The aim was to understand and illustrate pharmacist experiences of providing NSP.
Methods: Of the 107 eligible pharmacies, a total of 70 participated in the national evaluation. Telephone
interviews (n ¼ 17) and one-to-one interviews (n ¼ 13) using a semi-structured guide were conducted with
30 pharmacists. Analysis of data was conducted using the Empirical Phenomenological Psychological
(EPP) ﬁve step protocol.
Results: Pharmacist experiences illustrated the largely positive nature of providing NSP, and highlighted
needs to develop harm reduction training for pharmacists and appropriate strategies to raise awareness,
provide exchange packs to meet the speciﬁc needs of the diverse populations of people who inject drugs and
ensure the development of trusting relationships and opportunities to engage within a conﬁdential service.
Conclusions: Further enhancement of NSP coverage and targeted service delivery within national care
pathways for drug and alcohol services is warranted.
 2016 Elsevier Inc. All rights reserved.
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Introduction
Community pharmacists are increasingly
acknowledged as under-utilized, important and
accessible health providers to drug users,
including people who inject drugs (PWID), and
most particularly in combatting the transmission
of HIV and other blood-borne virus (BBV)
infection.1,2 A mix of needle and syringe pro-
gramme (NSP) models such as ﬁxed location,
mobile/outreach and community pharmacy-
based can optimize service user access to harm
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reduction services.3–5 Given their unique and
accessible position in the community, pharmacists
and pharmacy staﬀ are ideally positioned to reach
PWID, who are covert, have concerns around an-
onymity and who become “more visible” when ac-
cessing community service settings such as
pharmacies.1,6 The advantages of community
pharmacy-based NSP include longer opening
hours, convenience, contact with health profes-
sionals, ability to engage with small numbers of
service users in one place, and facilitate referral
onto addiction and other medical services.7
Harm reduction roles for community pharmacists
include the provision of injecting equipment,
dispensing methadone for treatment of opiate de-
pendents and sale/supply of condoms. NSP pro-
vided in community pharmacies demonstrate
considerable beneﬁts for PWID and the public.8,9
NSP initiation is reported to be inversely associ-
ated with obtaining syringes at pharmacies and re-
porting needle sharing.10 Convenience, reduced
stigma and anonymity for PWID in accessing ster-
ile injecting equipment, onsite HIV and Hepatitis
C testing in pharmacies, provision of harm reduc-
tion advice, referrals to social (housing and eligi-
bility assistance) and medical services, and entry
and retention in detoxiﬁcation programmes are
also reported.1,11–17 Other studies report reduced
heroin use, criminal activity, and HIV infection
rates, and the positive engagement with social
drug users vulnerable to developing high risk be-
haviors.18–20 Marked declines in the incidence of
HCV infection are reported where targeted risk
reduction eﬀorts for the prevention of HIV were
implemented.21 There is currently limited evidence
regarding the pharmacy as a setting for BBV ser-
vices, however in the UK dry blood spot testing
for HCV in the pharmacy has been successfully
oﬀered in the pharmacy and linked into vaccina-
tion, referral and treatment pathways.22 In the
UK, NICE guidance recommends the commis-
sioning of integrated care pathways for PWID.23
Community pharmacy-based NSP complement
ﬁxed and outreach based models as they facilitate
access to diﬀerent populations of injecting drug
users.3,7 More recently in 2015/2016, emergent
trends in injecting of performance and image
enhancement drugs and new psychoactive sub-
stances warrant continued provision of harm
reduction services in community pharmacy.24
It is important to understand the experiences
of pharmacists providing the service to ensure
continued engagement and eﬀective service provi-
sion for those already accessing services, whilst
also increasing access for other PWID not
currently engaging. Matheson et al25 in their study
in Scotland reported how addressing negative atti-
tudes could encourage greater pharmacy partici-
pation in provision of NSP services, and also
enhance the service delivery itself. In a later study,
Matheson et al14,26 also described how increased
exposure to PWID can stimulate positive attitude
change, and how changes in pharmacy practices
can enhance provision eﬃciency in terms of phar-
macist laying down of ground rules with service
users, requiring identiﬁcation, pre-prepared
packs, and providing verbal advice and leaﬂets
around harm reduction. Their studies also noted
a doubling in uptake of drug misuse training
following implementation of the service. Mathe-
son et al27 reported in 2016 that pharmacy work-
force attitudes and service user engagement with
the needle exchange process could further improve
over time, and do require greater embedding
within addiction teams.
NSP services were ﬁrst provided in Ireland in
1989 in the former Eastern Health Board AIDS
Resource Centre in Dublin, in response to the
heroin problem in the capital at the time.7 Ireland
reports the highest rate of heroin use in Europe
with just over 7 cases per 1000 population.28
Most recent National Drug Treatment Reporting
System (NTDRS) data estimates that there are be-
tween 18,136 and 23,576 opioid users resident in
Ireland.28 Small increases were evident in numbers
reporting opioids as primary and secondary prob-
lematic drug, with increases most notable in the
older drug using population.29 Opioid use preva-
lence among Irish females has increased since
2001.28 Irish Focal Point data for 2012 indicated
that 3971 of those entering treatment reported
opioids, mainly heroin as their primary problem
drug, with 45% reporting injecting use. In 2012 in-
jecting drug use (IDU) accounted for 76% of all
Hepatitis C virus diagnoses.
The National Drugs Strategy 2009–2016 has
highlighted the limited availability of NSP services
in ﬁve of the 10 Regional Drug Task Forces and
in 13 out of 14 Local Drug Task Forces.30 The na-
tional Pharmacy Needle Exchange (PNEX) pro-
gramme commenced in 2011. The PNEX
programme is a partnership initiative between
the Elton John Aids Foundation, Irish Pharmacy
Union and the Health Service Executive (HSE).
The development and implementation of the
PNEX programme was closely aligned with Ac-
tion 34 of the National Drug Strategy 2009–
2016 to “expand the availability of, and access to
needle exchange services (where required).” The
aim of PNEX programme was to increase access
to needle and syringe exchange for people who
inject drugs, and more broadly to reduce the risk
of HIV and other blood-borne viruses in Ireland
by rolling out provision of needle exchange ser-
vices within pharmacies.7 Prior to the PNEX,
NSP services were mainly located in the east of
Ireland, and provided by statutory and voluntary
agencies funded by the Health Service Executive
(HSE). The PNEX programme covers all areas
outside of Co. Dublin, Co. Wicklow and Co.
Kildare. Its speciﬁc aims cited directly from the
recent review of needle exchange provision in
Ireland by Bingham et al7 (p8) are as follows;
The PNEX programme provides sterile inject-
ing equipment, condoms and facilitates the return
of used equipment in order to prevent the spread
of BBVs. Pharmacies also refer individuals to
drug treatment; BBV/testing; Hepatitis B vacci-
nation and homeless services. Data submitted by
pharmacies to the PNEX programme indicates
that low numbers of referrals were made in 2013,
suggesting that increased referrals are needed not
just for specialist groups but for all clients access-
ing pharmacy needle exchanges.
The research was undertaken as part of the
national evaluation of the three year pilot stage of
the PNEX in 2014. The PNEX at the time of the
evaluation reported 26,196 needle exchange trans-
actions, with approximately 600–1100 unique
individuals attending each month, of which 70%
were males (mean age 32 years) and 30% females
(mean age 30 years). In the vast majority of
transactions the service user injected opioids. In
small numbers of transactions only, service users
were recorded as injecting anabolic steroids, tan-
ning agents and cocaine/amphetamines. Speciﬁc
referrals to treatment services (n ¼ 436), BBV
testing (n ¼ 402) and Hepatitis B vaccinations
(n ¼ 262), and an additional 74 referrals to other
unspeciﬁed services were recorded. We report here
on the qualitative element of the evaluation con-
ducted with pharmacists in order to understand
and illustrate pharmacist experiences of toward
providing needle exchange services.
Material and methods
The national evaluation of the three year pilot
stage of the PNEX was conducted in 2014. This
involved a mixed method approach using a na-
tional survey and interviews conducted with
pharmacists, and service users. All pharmacies
participating in the PNEX programme in April
2014 were eligible to take part in the evaluation.
The aims of the evaluation were to:
1. To understand client and stakeholder satis-
faction with needle exchange and attitudes to-
wards and experiences of, these services.
2. To provide data relating to safer injecting,
safer sexual behavior and the prevalence of
blood-borne viruses that can be used in com-
parison to international literature and can be
measured against in future evaluations.
3. To provide recommendations regarding the
development and delivery of services and
policy.
The Irish Pharmacy Union and the PNEX
programme contacted pharmacies participating
in the programme to inform them of the purpose
of the project and their support for it. The
research team contacted eligible pharmacies
participating in the PNEX programme via email
with follow-up telephone call, and asked phar-
macists to complete the online survey, participate
in an interview with a member of the research
team and encourage service users to take part in
the research through interviews. Non-responding
pharmacies were contacted by telephone on a
minimum of two further occasions and asked to
participate in the study.
In terms of the qualitative element of the
research, of the 107 eligible pharmacies
1. Prevent the spread of HIV and Hepatitis C through
reducing their transmission by providing sterile in-
jecting equipment
2. Prevent the development of localized bacterial in-
fections, such as abscesses, by providing sterile in-
jecting equipment
3. Prevent overdose through information on how to
recognize it and what to do should it occur
4. Prevent the move from smoking to injecting and
lower the incidence of injecting through the provi-
sion of tinfoil
5. Facilitate sterile and safe injecting through the pro-
vision of equipment, information and safer injecting
training
6. Provide information on the importance and avail-
ability of HIV and Hepatitis C testing
7. Manage localized bacterial infections through
referral for the provision of sterile dressing and
medication (where necessary)
8. Provide information to the drug user in respect of
relevant social and addiction services and refer the
drug user to same when appropriate
participating in the PNEX programme, 30 pharma-
cists (9 males and 21 females) located across Ireland
agreed to partake in the interviews. Reasons for not
participating included refusal, the NSP service was
not yet operational or had ceased tooperate and that
NSP was operating but no clients had attended the
service at the time of the evaluation.
Based on the aims 1 and 3 of the evaluation,
consultation with extant literature and several
meetings of the research team, a semi-structured
interview guide was designed to examine pharma-
cist perceptions and experiences of delivering
needle exchange including client proﬁle, equip-
ment provision, service provision, service suc-
cesses, barriers towards service delivery and data
monitoring processes. Interviews were conducted
by author 2, a trained researcher. Ethical approval
for the evaluation protocol was granted by Liver-
pool John Moores University, UK. Prior to
agreeing a date and time for conducting inter-
views, participants were provided via email with
information about the research objectives,
informed that they would be recorded, and also
their right to withdraw from the research at any
time. Written consent was given by all partici-
pants who partook in face to face interviews, with
verbal consent provided via telephone. Interviews
were conducted via telephone (n ¼ 17) and face to
face (n ¼ 13), lasted 45–90 min and audio-
recorded with permission.
Audio ﬁles were transcribed with the data
hand coded with analysis with support from
QSR NVivo 10 using the Empirical Phenomeno-
logical Psychological (EPP) ﬁve step method.31
This method emphasizes an open, non-
judgmental and bias free attitude to interpreta-
tion of data, with respect to the participants
and is underpinned by the facilitation of the
meaning of lived phenomena,31,32 in this instance
describing the experiences of pharmacists in
providing needle exchange and interacting with
service users. The steps involved the following
analytical process conducted by author 4, and
in consultation with author 2. The data ﬁle was
read three times so as to familiarize, identify psy-
chological phenomena and achieve an overview
of the codeine misuse phenomenon in an unbi-
ased and open manner, and in the absence of
any speciﬁc hypothesis. Theoretical reﬂection
was withheld at this step. The text was then
divided into smaller meaning units (MU),
without regard to syntax, included whole para-
graphs to single words, and each time a new
meaning, focus or topic was introduced. All
MUs were subsequently transformed from the
participants wording and restated in order to
present signiﬁcant and implicit meanings in ob-
jectivized terms. In order to obtain interpretative
validity32 considerable eﬀorts were made to
ensure respect of the participants’ experience.
The restated MUs were categorized by repeated
consultation with the raw data, scrutinizing
that the category itself was maintained, the un-
derstanding of what the phenomenon is (noema)
and how it is expressed (noesis) and by consid-
ering speciﬁc characteristics and similarities in
participant experiences of NSP provision. The
generated categories were then part of an
abstraction process to create more general and
overarching themes through the patterns identi-
ﬁed within related categories.
Results
Seven descriptive themes emerged from the
analysis, and we present them as follows with
illustrative quotes.
Operation of the needle exchange
In general the needle exchange service was
observed by all participants to be working well in
their pharmacy and creating useful points of
regular and transient contact with PWID. The
service was described as quick and eﬃcient with
minimal impact on the running of other pharmacy
activities.
‘We are a really busy pharmacy and I did worry
about if they have to wait when they come in and
would that be a problem, but it’s actually been really
well. I think it’s been going a lot better than expected
and we have had a lot more exchanges than expected
as well.’ Participant #11
The needle exchange as point of contact in
providing clean injecting equipment was deemed
as important by all participants in promoting safe
injecting practices as well as the dissemination of
harm reduction and health related information,
and provision of medical support and treatment
referral from the community pharmacy. One
participant observed;
‘I think the opportunity I suppose to have engage-
ment with people that might not otherwise get
opportunities to engage with healthcare profes-
sionals, it’s satisfying.’ Participant #17
Main street and city center pharmacies were
viewed by the majority to be better locations for
providing needle exchange services, due to lack of
transport for many service users. Some pharmacy
needle exchanges also dispensed methadone to
service users. In terms of operation of the needle
exchange in the pharmacy, practical consider-
ations included the need for pharmacy staﬀ to
be vaccinated against Hepatitis B, and the regular
collecting of bins containing used needles.
Service user awareness and uptake of the service
Participants described service user proﬁles as
ranging from young drug users to older, long-term
PWID. Age was viewed as diﬃcult to determine at
times, but most dates of birth supplied placed
service users ranged between mid-teens to mid-
forties in age. Some service users were described by
participants as engaging on behalf of others. In
general, male service users were perceived as more
common than female. Poly substance use and issues
with homelessness were reported by all partici-
pants. Some service users were described as not
accessing other services, with a minority waiting to
access treatment. Relapse instances were described
as common amongst those receiving treatment.
‘Most are quite young. Living in hostels or some sort
of subsidized housing Most of them ﬁt into that
category. They seem to have no social supports
only more of that peer group. We have very few
maybe over 40, 1 or 2. They don’t live that long or
they come oﬀ the program before that age. Quite a
few foreigners, Polish, Lithuanian, European
origin. More male than female, well more males
seem to make the contact as opposed to the females.
The females tend to be better to return them.’
Participant #2
Uptake of the needle exchange service ap-
peared to be dependent on heroin availability in
some of the community pharmacies. Half of
participants commented on the need for their
pharmacy to increase service user uptake. One
participant observed;
‘It’s ok it’s just that we don’t have an awful lot of
clients, we’ve tried to address that but obviously
you can’t make people come to a place or location
if they don’t want to.’ Participant #24
Increasing uptake was reported in other sites,
but with no change in gender proﬁles. Recent
changes in service user proﬁle centered on partic-
ipant observations of increasingly younger users
and members of the Irish Traveler (Gypsy)
Community requesting needles for the injecting
of melanotan, a synthetic tanning peptide hor-
mone and anabolic androgenic steroids. A rise in
uptake from migrant groups from Eastern Europe
was observed by some pharmacy sites. Word of
mouth, for the most part, was viewed as most
likely to alert PWID to provision of the service,
with several comments made by participants
around the lack of familiarity of users with the
needle exchange logo visible at pharmacy entry
point. Access and continued uptake by service
users was perceived to be facilitated by speedy
transactions, provision of private entry in some
sites, and exchanges with staﬀ occurring in private
consultation rooms.
‘Anybody who comes in wants to get out as quick
as possible, you know they don’t want to be
hanging about they don’t want anybody to see
them, so ﬁne. Now we haven’t had really much has-
sle with anybody, everyone is ﬁne.’ Participant #4
Participant experiences with service users were
generally very positive. The majority of service
users accessed the needle exchange alone. For the
most part, service users were viewed to be polite,
mannerly and abiding by the rules of the shop.
This was viewed by participants to be grounded in
verbal instruction and ground rules for acceptable
behavior provided by the pharmacist. Some minor
incidents of visible intoxication and shoplifting
were reported.
‘Overall they’re usually quite friendly and appre-
ciative. Sometime they’re a bit agitated or in a
rush, you know you can understand that, or if
they’re having a bad week or whatever, but like I
say we’ve only had one or two problems.’ Partici-
pant #23
There was evidence of residual concerns and
some continued mistrust of PWID. This can be
seen in the comments:
‘because they have a tendency to steal, you tend to
deal with them maybe quicker than you might want
to ordinarily’ where the participants have concerns
about the honesty of the clients, the impact of
multiple NSP clients on other customers’.
Participant#18
A further example can be seen in the case of a
pharmacist who felt obliged to speciﬁcally ask the
staﬀ if they have ‘had any incidents with clients,’
despite the lack of evidence to suggest any risk.
The needle exchange transaction
The needle exchange transaction itself was
viewed as eﬃcient, but in some instances
hampered by poor dialog and opportunity for
engagement between pharmacist and service user,
and low return rates of used sharps. Some
participants reported never receiving used packs
in return for new equipment but continued to
emphasize the need to advise service users on the
safe disposal of used needles and equipment. Such
eﬀorts to encourage the needle exchange trans-
action were described by participants as contrib-
uting to increased rates of return over time. The
more middle class user (as perceived by partici-
pants) was deemed to be more responsible in
returning used packs.
‘It’s a prompt service, the very minute they come
it’s there, they are dealt with. I go through the
pack with all the new customers that come in and
I ask them do they have any empties so I think
the service is ﬁne, you know I’m not judgmental
to them I just wish they’d bring back the packs,
like they’re getting it for free you know.’ Partici-
pant #5
Some comments were made that the needle
exchange transactions could be improved in terms
of level of engagement with the user. The ex-
change itself was described by the majority as a
quick process, with service users appearing
anxious to leave the site. Lack of interaction was
generally due to service user reluctance to engage,
and pharmacist lack of time caused by busy retail
and dispensing environments. Some participants
described visible service user impatience in waiting
their turn for the needle exchange transaction.
Possible reasons for this included opiate craving
and the stigma of IDU.
‘We do have a ‘1 in’ policy. So that you’re not hav-
ing a string of them coming in at once where it’s
too overpowering.’ Participant #3
Conﬁdentiality and discretion on the part of
pharmacists engaged in the needle exchange trans-
action was viewed as important in ensuring
continued uptake of the service. Private consulta-
tion rooms were useful in promoting a conﬁden-
tial service. Communication between adjunct
pharmacy staﬀ (dispensing technicians and point
of sale) was viewed as important in monitoring the
service itself and the experience of staﬀ. One
participant observed;
‘The girls [staﬀ] are happy with the service. I do
keep a check with them ask like “have you any
problems, is there anything more I can do, is there
anything more we need to provide for our clients or
any incidences where you have had an incident with
a client”.’ Participant #3
Service user information was recorded as per
the protocols of providing the needle exchange
service. Some participants observed that they were
unsure whether the exchange was for the service
user themselves, particularly when attempting to
access needle exchange without ‘empties,’ and
comments were made around conﬁrmation of
identity and frequent supply of false names. Im-
provements in data capture and submission was
viewed by one participant as warranting a speciﬁc
electronic system.
‘I say to them all the time but like we never get any
empties back here, never ever. But they do give me
the information, their names and date of births but
sure they could be anyone’. Participant #5
The needle exchange packs
Many positive comments were made around
the contents of the provided safe injecting kits.
Pack size options were described by the majority
of participants as optimizing eﬃciency and discre-
tion for the user, and that service users generally
chose to take the ‘three needle’ pack. Some
comments were made around encouraging use of
10 packs, in order to reduce sharing activity.
Other participants disagreed with 10 packs for
wastage reasons. One participant observed;
“A lot of times they prefer the 3 packs, I think its
size, portability and the lads like to stick it in their
pocket rather than carry it in the pharmacy bag,
they think people know what’s in the bag” Partic-
ipant #23
Many participants observed that service users
reported to them that needles and syringes pro-
vided are not the right size or right volume, with
many describing them as too small. Some service
users as a consequence were described as purchas-
ing diabetic needles. Some requests for longer
needles for groin injecting were also reported. One
participant observed;
‘Well the kits are inﬂexible and we do get requests
for alternatives in terms of needles and we only
have a very inﬂexible set that we can give out. I
think we are pharmacists after all we can dispense
things up. So that would be something that could be
better’ Participant #9
Some participants observed the need for pro-
vided packs to provide more alcohol wipes, citric
and alternative types of needles. Tourniquets are
also viewed as warranting inclusion in the pack.
Three packs do not contain condoms, and this
was queried by some service users. Most pharma-
cies reported providing the water separately,
which was also viewed by some as warranting
inclusion in the pack.
‘Some people ask for extra citric with the smaller
packs and we don’t have the citric on their own,
they are all packed individually with the needles.
Some people look for individual needles. We try
and discourage that because we want them to
take the box with them so they have something to
put them into.’ Participant #2
Other comments centered on advising service
users to use the small black kit in the ‘three’ pack
for disposal and storage of used needles. Service
users in some instances weren’t aware that this can
be used to store used needles. Having the sharps
bin as separate to the provided needles was viewed
as safer by some participants.
Relationships and trust
The development of a relationship based on
‘respect, empathy and harm reduction’ between ser-
vice users and staﬀ was viewed by all as important
in increasing uptake in the needle exchange, and
reducing unsafe injecting practices. First contact
characterized by friendliness on the part of the
pharmacist and frontline staﬀ was viewed by
many as vital in creating the initial steps of a rela-
tionship. Other comments centered on providing
support in a friendly and non-judgmental
atmosphere.
‘I do think that we do establish contact with them. I
think it’s very important that ﬁrst contact, that it’s
not too aggressive and gets them to back oﬀ, that
its open and friendly, and I think we do that
well.’ Participant #2
Use of private consultation rooms was viewed
by many as important in relationship building and
pharmacist assistance in dealing with service user
health related queries. Despite these rooms, the
needle exchange service itself was deemed by the
majority as characterized by lack of interaction
and the consequent speed of the process. This
however was also observed to reduce the oppor-
tunity to engage in dialog around injecting behav-
iors, health needs, concerns and requests for help.
‘if they come in for anything like that because they
have a tendency to steal, you tend to deal with them
maybe quicker than you might want to ordinarily,
But it can be done pretty quickly, in other words,
sometimes a raised eyebrow will tell me what
they want, so I can get ahead and give it to
them.’ Participant #18
Trust was viewed by participants as important
in continued uptake of the service and was viewed
as setting the foundation for volunteering of
information from service users over time.
Participants were very positive about providing
the service in an eﬃcient and discreet manner.
Comments included;
‘I think they can talk to the pharmacists and they
trust them well, they kind of know them at this
stage’ Participant #13
Provision of health advice and referrals
Health advice, sexual health and wound care
(advice and dressings) was oﬀered in most sites,
with at the minimum, advice leaﬂets in the pro-
vided packs given. General advice also centered
on wetting the ﬁlter prior to injecting. The
development of a series of health related questions
and training on how to provide harm reduction
advice around safe injecting, overdose prevention
and overdose emergency actions were viewed by
some as warranting development. Other needs
include local referral information and provision of
leaﬂeting on HIV and hepatitis vaccination in the
pharmacy. Comments included;
‘If they have obvious wounds on their hands we
would assess them as they come in and say, oh
look you need to go to see a doctor with that,
that needs to be looked at, that’s infected – things
like that.’ Participant #2
‘I do try and get them to talk about their health or
lack of, you know. Personal care also. Sometimes
they’ll tell me and sometimes they’ll sit down and
tell me their whole life story.’ Participant #27
The majority of pharmacies engaged with local
community drug services and methadone clinics,
but with all participants observing the need for
greater visibility of drug and alcohol services and
referral routes. Some were aware of local treat-
ment and detoxiﬁcation services and referred
service users to these when requested. Waiting
times at these services were viewed as detrimental
to service user treatment decision-making. Com-
ments included;
‘All we can do is recommend people to seek help
and point them in directions. But we’ve no means
of tracking whether they present or (not). We
tend to see the same people the whole time, you
know we might get a new person every so often
and people disappear.’ Participant #20
Training needs and support
The majority of participants were satisﬁed with
the needle exchange training provided. For the
most part, continued training is needed on speciﬁc
health related questioning and on where to refer
service users to in terms of health, medical and
treatment services. One participant observed;
‘what I think I’d like is a bit more information
about if they want to come oﬀ, the drug using
and the needles and stuﬀ like that. But I do think
it’s a really good service, but there is room to
improve.’ Participant #22
Some participants described needing more in-
formation and speciﬁc training on the injecting
needs for steroid and synthetic tanning (melano-
tan) injecting.
‘Some people are using them for tan or steroids or
something like that. Now I wouldn’t be familiar
with anything like that so I wouldn’t know what
to advise or how to advise.’ Participant #2
Discussion
We present here the qualitative ﬁndings gath-
ered as part of the national evaluation of the
PNEX pilot in Ireland. Limitations of the study
center on the convenience sample aspects of
participant recruitment, self-reporting of views
and experiences, and the potential for researcher
biases and idiosyncracies. Validity of the study is
however optimized by the trustworthiness of the
data in veriﬁcation of extensive similarities across
participant narratives, and horizontal consistency
and vertical consistency in the interpretation of
data.32
Pharmacist experiences illustrated the positive
nature of providing the service, and were encour-
aged by rising rates of uptake over time. Data
recorded in the preceding year, indicated that
numbers of people attending the needle exchange
services in Irish pharmacies increased throughout
2013, suggesting that the programme was success-
fully engaging with PWID and increasing access
to clean injecting equipment and contact with
health professionals. The provision of pharmacy-
based needle exchanges in a variety of rural and
urban settings is likely to be a key step towards
achieving broad coverage across Ireland and
reducing the risk of BBV transmission in Ireland.
Of note is that pharmacists in their capacity as
health providers are more likely to provide harm
reduction services if their communities demand
them.1,16–19,33,34
Pharmacist experiences illustrated the positive
nature of providing needle exchange services In
contrast, ﬁndings elsewhere have illustrated more
negative views, where some pharmacists have
disclosed negative attitudes towards PWID and
although attitudes towards the provision of
services in pharmacies for PWID have generally
improved in recent years they are still mixed.35–37
Recent systematic reviews have underscored the
general positive attitude to providing harm reduc-
tion advice in pharmacies, with common barriers
centering on lack of time and speciﬁc training,
fear of attracting diﬃcult service users, insuﬃcient
remuneration, and diﬃculties in communicating
with adjunct health providers.2 Of note for this pi-
lot programme going forward, and building on
the goodwill and positive attitude toward
providing NSP, is that service user perceptions
of negative staﬀ attitudes and experiences of
discrimination have been associated with
increased risk of needle sharing activities38 and
the impact of needle and syringe exchange services
on BBV infection may be greater where clients
engage in other health interventions in addition
to needle exchange.39 Equally, the attitudes of
pharmacy staﬀ towards service provision may
improve with training11,16,35 and with increased
experience of providing services.14 Where the nee-
dle exchange is a new service within the pharmacy,
it might be expected that attitudes and relation-
ships with clients improve with familiarity.14,26
Tesoriero et al15 reported no increase in crime or
staﬀ/customer discomfort following implementa-
tion of needle and syringe exchange despite initial
concerns. Many of the comments by participating
pharmacists were positive with regard to the pro-
vision of sterile injecting equipment and were
largely supportive of the actual client group.
However, there was evidence of residual concerns
and some continued mistrust of PWID.
Low return rates of used sharps were reported
and requests for particular syringes are similar to
studies conducted elsewhere.1,40–42 The World
Health Organization43 and National Institute for
Health and Care Excellence (NICE)23 emphasize
that increasing the coverage of sterile injecting
equipment to PWID, towards the goal of a sterile
syringe and needle for every injection is of para-
mount importance, in the prevention of blood-
borne virus transmission. However, eﬀective
disposal systems for used equipment are vital for
improving the safety of communities and tackling
negative attitudes towards needle exchange pro-
grammes. The mixed views of pharmacy staﬀ in
this qualitative study on the best methods to
encourage returns of used needles and equipment
suggests that the provision of consistent informa-
tion to pharmacy staﬀ through training is
required. Providing those using the needle ex-
change with advice and information on disposal
and making it simple for them to make returns is
likely to be beneﬁcial. It is important to again
consider the privacy of those clients who wish to
safely dispose of their equipment in the pharmacy.
With increased engagement between staﬀ and cli-
ents in the pharmacy, it may be likely that rates of
returns will improve.
Despite the speed of the needle exchange
transaction itself and restriction to one service
user at a time, pharmacists in this Irish study
voiced intentions to develop trusting relationships
and opportunities to engage with service users
within a conﬁdential service. Relationships with
needle exchange service users are paramount to
continued uptake, increased reach to other PWID
or those users at risk of injecting, and the referrals
toward ancillary social, medical and treatment
services.40,44,45 It is regrettable that pharmacy
models in busy retail environments to a certain
extent are restricted by time pressures and staﬀ
availability. Increased contact and engagement
between staﬀ and clients is likely to increase trust
and improve relationships. It was reported that
transactions were typically quick and, particularly
with new clients, there was a reluctance to engage
fully. Creating an environment where clients feel
comfortable is therefore important to maximize
the beneﬁts of the service. Concerns about privacy
and conﬁdentiality have been identiﬁed as a bar-
rier to the delivery of public health services in
pharmacies37,46 including to PWID.47 Guidance
for pharmacies in the UK states that service users
and pharmacists should be able to sit down
together and speak to each other without being
overheard by other customers or staﬀ. The provi-
sion of consultation rooms where clients can
discuss their drug use and related health concerns
with pharmacy staﬀ may lead to increased uptake
of services and improved relationships between
staﬀ and clients.
Pharmacists in this Irish evaluation expressed
needs in relation to speciﬁc harm reduction
training, speciﬁc promotional leaﬂets to raise
awareness in their communities, and the provision
of ‘ﬁt for purpose’ exchange packs particular to
the needs of their service users. For example, in
some areas, emergent trends included the injecting
use of performance and image enhancement
drugs, as distinct from the traditional PWID.
Speciﬁc service user and staﬀ training needs
therefore appeared to center on injecting use of
steroids and tanning injections. This client group
are of particular signiﬁcance to needle and syringe
programmes as they now account for over half of
all clients the UK,48 with increasing numbers also
being reported in Australia49 while a recent meta-
analysis indicated a global lifetime prevalence of
3.3%. Perhaps of even greater concern, is the evi-
dence from the UK relating to HIV. HIV preva-
lence levels of between 1.5% and 2% amongst
those who inject anabolic steroids and associated
drugs, the same level as people who inject heroin
or crack cocaine.50,51 Hepatitis B and C were
also identiﬁed in this population, together with
concerning levels of localized infection and
injury.52 Pharmacists required some training on
where to refer to, and should over time nestle
within an interagency approach to dealing with
addiction in the community.
The epidemiology, behavior and associated
risks amongst PWID is dynamic in nature. There
are indications that Ireland, like the UK, will
experience increases in those injecting PIEDs, a
widening pharmacopeia53 including anabolic ste-
roids, growth hormones and tanning agents,
together with an ever changing array of novel psy-
choactive substances.54 It is essential that the
changing proﬁle of injectors is acknowledged
and appropriate training developed and delivered.
Conclusion
Pharmacist experiences illustrated the positive
nature of providing the needle exchange service,
and highlighted needs to develop speciﬁc harm
reduction training for pharmacists, implement
appropriate strategies to raise awareness of the
services with PWID provide injecting equipment
to meet the speciﬁc needs of their diverse service
users and ensure the development of trusting
relationships and opportunities to engage within
a conﬁdential service.
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